Joint Symposium of Osaka University, University of  California, Davis, and Kirin Holdings Co. Ltd.   Date; November 10 (Wed), 2021 Time; 9:00 – 12:00 (JST)   Title; Plant Cell Bioprocessing of Human Growth Factors and Other  Bioactive Proteins  Venue; On-line system   Research collaborations between the University of California, Davis, Osaka  University and Kirin Holdings Co., Ltd., Japan have launched in 2018. Production of pharmaceuticals in plant and examination of plant-made pharmaceuticals will pave feasible and commercially practicable ways.  The regenerative cure industry has made remarkable progress, and some therapies,such as Chimeric Antigen Receptor T cells, CAR-T, have begun to be put to practical use for diseases that were previously difficult to treat, and have produced excellent results. However, cell growth factors, one of the most important raw materials used in culturing cells for these therapies, are very expensive due to the difficulty in manufacturing and ensuring high quality. As a result, these treatment methods cannot be said to be medical care that everyone with the target disease can receive. Therefore, in order to solve these problems, the production of growth factors in plant cells has been studied. In this symposium, the physicochemical properties of growth factors produced in plant cells, their effectiveness in cell culture, and their potential for industrial  production will be introduced.  Partnership leaders gathered for  a signing ceremony  at the UC Davis Alumni Center.  (2019.06.21)  Time schedule   UC Davis Plant Cell Bioprocessing of Human Growth Factors and Other Bioactive Proteins

UC Davis Biotechnology Program  https://biotech2.sf.ucdavis.edu/news/joint-symposium-osaka-university-uc-davis-and-kirin-holdings-co-ltd  If you would like to participate, please send an email to the following address with your organization, name and email address.

詳細はこちら